A SYSTEMATIC REVIEW OF THE CHROMIUM CONTENT OF THE NORMAL HUMAN PROSTATE GLAND
The prostate gland is subject to various disorders. The etiology and pathogenesis of these diseases remain not well understood. Moreover, despite technological advancements, the differential diagnosis of prostate disorders has become progressively more complex and controversial. It was suggested that the chromium (Cr) level in prostatic tissue plays an important role in prostatic carcinogenesis and its measurement may be useful as a cancer biomarker. These suggestions promoted more detailed studies of the Cr content in the prostatic tissue of healthy subjects. The present study evaluated by systematic analysis the published data for Cr content analyzed in prostatic tissue of “normal” glands. This evaluation reviewed 1958 studies, all of which were published in the years from 1921 to 2020 and were located by searching the databases PubMed, Scopus, ELSEVIER-EMBASE, Cochrane Library, and the Web of Science. The articles were analyzed and “Median of Means” and “Range of Means” were used to examine heterogeneity of the measured Cr content in prostates of apparently healthy men. The objective analysis was performed on data from the 28 studies, which included 1282 subjects. It was found that the range of means of prostatic Cr content reported in the literature for “normal” gland varies widely from 0.009 mg/kg to 0.34 mg/kg with median of means 0.095 mg/kg on a wet mass basis. The level of intra-prostatic metal does not depend on age and androgen status. Finally, because of small sample size and high data heterogeneity, we recommend other primary studies be performed.
2. Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 2017;4:148-51.
3. Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10:63-89.
4. Avisyn AP, Dunchik VN, Zhavoronkov AA, Zaichick V, Sviridova TV. Histological structure of the prostate and content of zinc in it during various age period. Arch Ana Gistol Ebriol 1981;81:76-83.
5. Zaichick V. INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. J Radioanal Nucl Chem 2004;262:229-34.
6. Zaichick V, Zaichick S. The effect of age on Br, Ca, Cl, K, Mg, Mn, and Na mass fraction in pediatric and young adult prostate glands investigated by neutron activation analysis. Appl Radiat Isot 2013;82:145-51.
7. Zaichick V, Zaichick S. INAA application in the assessment of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn mass fraction in pediatric and young adult prostate glands. J Radioanal Nucl Chem 2013;298:1559-66.
8. Zaichick V, Zaichick S. NAA-SLR and ICP-AES application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands. Biol Trace Elem Res 2013;156:357-66.
9. Zaichick V, Zaichick S. Use of neutron activation analysis and inductively coupled plasma mass spectrometry for the determination of trace elements in pediatric and young adult prostate. Am J Anal Chem 2013;4:696-706.
10. Zaichick V, Zaichick S. Relations of bromine, iron, rubidium, strontium, and zinc content to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. Biol Trace Elem Res 2014;157:195-204.
11. Zaichick V, Zaichick S. Relations of the neutron activation analysis data to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. Adv Biomed Sci Eng 2014;1:26-42.
12. Zaichick V, Zaichick S. Relations of the Al, B, Ba, Br, Ca, Cl, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Si, Sr, and Zn mass fractions to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands. Biometals 2014;27:333-48.
13. Zaichick V, Zaichick S. Androgen-dependent chemical elements of prostate gland. Androl Gynecol Curr Res 2014;2:2.
14. Zaichick V, Zaichick S. The distribution of 54 trace elements including zinc in pediatric and nonhyperplastic young adult prostate gland tissues. J Clin Lab Investig Updates 2014;2:1-15.
15. Zaichick V, Zaichick S. Differences and relationships between morphometric parameters and zinc content in nonhyperplastic and hyperplastic prostate glands. Br J Med Med Res 2015;8:692-706.
16. Schwartz MK. Role of trace elements in cancer. Cancer Res 1975;35:3481-7.
17. Zaichick V, Zaichick S. Role of zinc in prostate cancerogenesis. In: Mengen Und Spurenelemente. 19, Arbeitstagung, Jena: Friedrich Schiller Universitat; 1999. p. 104-15.
18. Zaichick V, Zaichick S. Wynchank S. Intracellular zinc excess as one of the main factors in the etiology of prostate cancer. J Anal Oncol 2016;5:124-31.
19. Zaichick V, Zaichick S, Rossmann M. Intracellular calcium excess as one of the main factors in the etiology of prostate cancer. AIMS Mol Sci 2016;3:635-47.
20. Krstev S, Knutsson A. Occupational risk factors for prostate cancer: A meta-analysis. J Cancer Prev Act 2019;24:91-111.
21. Dunchik V, Zherbin E, Zaichick V, Leonov A, Sviridova T. Method for differential diagnostics of prostate malignant and benign tumours. Russian patent (Author’s Certificate No 764660, priority of invention 27.10.1977). Discov Inventions Commer Models Trade Marks 1980;35:13.
22. Zaichick V, Sviridova T, Zaichick S. Zinc in the human prostate gland: Normal, hyperplastic and cancerous. Int Urol Nephrol 1997;29:565-74.
23. Zaichick V, Sviridova T, Zaichick S. Zinc in human prostate gland: Normal, hyperplastic and cancerous. J Radioanal Nucl Chem 1997;217:157-61.
24. Zaichick S, Zaichick V. Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis. J Appl Radiat Isot 2012;70:81-7.
25. Zaichick V, Zaichick S. Ratios of selected chemical element contents in prostatic tissue as markers of malignancy. Hematol Med Oncol 2016;1:1-8.
26. Zaichick V, Zaichick S. Trace element levels in prostate gland as carcinoma’s markers. J Cancer Ther 2017;8:131-45.
27. Zaichick V, Zaichick S. Ratios of Zn/trace element contents in prostate gland as carcinoma’s markers. Cancer Rep Rev 2017;1:1-7.
28. Zakutinsky DI, Parfyenov YD, Selivanova LN. Data Book on the Radioactive Isotopes Toxicology. Moscow: State Publishing House of Medical Literature; 1962.
29. Bana? A, Kwiatek WM, Zaj?c W. Trace element analysis of tissue section by means of synchrotron radiation: The use of GNUPLOT for SPIXE spectra analysis. J Alloys Comp 2001;328:135-8.
30. Iyengar GV. Reevaluation of the trace element content in reference men. Radiat Phys Chem 1998;51:545-60.
31. Langard S, Andersen A, Ravnestad J. Incidence of cancer among ferrochromium and ferrosilicon workers: An extended observation period. Br J Ind Med 1990;47:14-9.
32. Jakobsson K, Mikoczy Z, Skerfving S. Deaths and tumours among workers grinding stainless steel: A follow up. Occup Environ Med 1997;54:825-9.
33. Linos A, Petralias A, Christophi CA, Christoforidou E, Kouroutou P, Stoltidis M, et al. Oral ingestion of hexavalent chromium through drinking water and cancer mortality in an industrial area of Greece--an ecological study. Environ Health 2011;10:50.
34. Chen QY, Murphy A, Sun H, Costa M. Molecular and epigenetic mechanisms of Cr(VI)-induced carcinogenesis. Toxicol Appl Pharmacol 2019;377:114636.
35. Deng Y, Wang M, Tian T, Lin S, Xu P, Zhou L, et al. The effect of hexavalent chromium on the incidence and mortality of human cancers: A meta-analysis based on published epidemiological cohort studies. Front Oncol 2019;9:24.
36. Zhang C, Cai K, Feng Q, Xu Y, Zhang Z. Chromium(VI) promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer. Toxicol Lett 2019;300:10-7.
37. Zaichick V. Medical elementology as a new scientific discipline. J Radioanal Nucl Chem 2006;269:303-9.
38. Anderson RA. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 1997;26:S35-41.
39. Pechova A, Pavlata L. Chromium as an essential nutrient: A review. Vet Med 2007;52:1-18.
40. Tipton JH, Steiner RL, Foland WD, Mueller J, Stanley M. USAEC ORNL Report CF 54-12-66. Tennessee: ORNL; 1954.
41. Koch HJ, Smith ER, Shimp NF, Connor J. Analysis of trace elements in tissue. I. Normal tissue. Cancer (Philad) 1956;9:499-511.
42. Tipton IH, Cook MJ. Trace elements in human tissue. Part II. Adult subjects from the United States. Health Phys 1963;9:103-45.
43. Kwiatek WM, Hanson AL, Paluszkiewicz C, Ga?ka M, Gajda M, Cichocki T. Application of SRIXE and XANES to the determination of the oxidation state of iron in prostate tissue sections. J Alloys Comp 2004;362:83-7.
44. Kwiatek WM, Banas A, Gajda M, Ga?ka M, Pawlicki B, Falkenberg G, et al. Cancerous tissues analyzed by SRIXE. J Alloys Comp 2005;401:173-7.
45. Guntupalli JN, Padala S, Gummuluri AV, Muktineni RK, Byreddy SR, Sreerama L, et al. Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique. Eur J Cancer Prev 2007;16:108-15.
46. Zaichick S, Zaichick V. The effect of age on Ag, Co, Cr, Fe, Hg, Sb, Sc, Se, and Zn contents in intact human prostate investigated by neutron activation analysis. Appl Radiat Isot 2011;69:827-33.
47. Zaichick S, Zaichick V, Nosenko S, Moskvina I. Mass fractions of 52 trace elements and zinc trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry. Biol Trace Elem Res 2012;149:171-83.
48. Zaichick V, Zaichick S. INAA application in the assessment of chemical element mass fractions in adult and geriatric prostate glands. Appl Radiat Isot 2014;90:62-73.
49. Zaichick V, Zaichick S. Use of INAA and ICP-MS for the assessment of trace element mass fractions in adult and geriatric prostate. J Radioanal Nucl Chem 2014;301:383-97.
50. Zaichick V, Zaichick S. Differences between chemical element contents in hyperplastic and nonhyperplastic prostate glands investigated by neutron activation analysis. Biol Trace Elem Res 2015;164:25-35.
51. Zaichick V. The variation with age of 67 macro-and microelement contents in nonhyperplastic prostate glands of adult and elderly males investigated by nuclear analytical and related methods. Biol Trace Elem Res 2015;168:44-60.
52. Zaichick V, Zaichick S. Variations in concentration and histological distribution of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn in nonhyperplastic prostate gland throughout adulthood. J Cell Mol Bio 2016;2:11.
53. Zaichick V, Zaichick S. Age-related changes in concentration and histological distribution of 54 trace elements in nonhyperplastic prostate of adults. Int Arch Urol Complic 2016;2:19.
54. Zaichick S, Zaichick V. Prostatic tissue levels of 43 trace elements in patients with BPH. Br J Med Med Res 2016;15:1-12.
55. Zaichick V, Zaichick S. Prostatic tissue levels of 43 trace elements in patients with prostate adenocarcinoma. Cancer Clin Oncol 2016;5:79-94.
56. Zaichick V, Zaichick S. Chemical element contents in normal and benign hyperplastic prostate. Ann Mens Health Wellness 2017;1:1006.
57. Zaichick V. Differences between 66 chemical element contents in normal and cancerous prostate. J Anal Oncol 2017;6:37-56.
58. Zaichick V, Zaichick S. Comparison of 66 chemical element contents in normal and benign hyperplastic prostate. Asian J Urol 2019;6:275-89.
59. Isaacs JT. Prostatic structure and function in relation to the etiology of prostatic cancer. Prostate 1983;4:351-66.
60. Leissner KM, Fielkegard B, Tisell LE. Concentration and content of zinc in human prostate. Invest Urol 1980;18:32-5.
61. Woodard HQ, White DR. The composition of body tissues. Br J Radiol 1986;59:1209-18.
62. Arnold WN, Thrasher JB. Selenium concentration in the prostate. Biol Trace Elem Res 2003;91:277-80.
63. Schroeder HA, Nason AP, Tipton IH, Balassa JJ. Essential trace metals in man: Zinc. Relation to environmental cadmium. J Chron Dis 1967;20:179-210.
64. Saltzman BE, Gross SB, Yeager DW, Meiners BG, Gartside PS. Total body burdens and tissue concentrations of lead, cadmium, copper, zinc, and ash in 55 human cadavers. Environ Res 1990;52:126-45.
65. Zaichick V. Sampling, sample storage and preparation of biomaterials for INAA in clinical medicine, occupational and environmental health. In: Harmonization of Health-related Environmental Measurements Using Nuclear and Isotopic Techniques. Vienna: IAEA; 1997. p. 123-33.
66. Zaichick V. Losses of chemical elements in biological samples under the dry ashing process. Trace Element Med 2004;5:17-22.
67. Zaichick V, Zaichick S. Instrumental effect on the contamination of biomedical samples in the course of sampling. J Anal Chem 1996;51:1200-5.
68. Mutuma S, Amuna P, Shukla H, Sumar S. Chromium in food, nutrition and health?an introduction. Nutr Food Sci 1999;99:81-8.
69. Afolaranmi GA, Tettey J, Meek RM, Grant MH. Release of chromium from orthopaedic arthroplasties. Open Orthop J 2008;2:10-8.
70. Vendittoli PA, Mottard S, Roy AG, Dupont C, Lavigne M. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg Br 2007;89:441-8.
71. Vernadsky VI. Living Matter. Moscow: Nauka; 1978.
72. Zaichick V, Ermidou-Pollet S, Pollet S. Medical elementology: A new scientific discipline. Trace Elements Electr 2007;24:69-74.
73. Papp JF. Chromium use by market in the United States. In: Transformation Through Technology. Proceedings of Tenth International Ferroalloys Congress-INFACON X (Cape Town, South Africa, 1-4 February 2004). Switzerland: Document Transformation Technologies; 2004. p. 770-8.
74. Cheng H, Zhou T, Li Q, Lu L, Lin C. Anthropogenic chromium emissions in China from 1990 to 2009. PLoS One 2014;9:e87753.
75. Wilbur S, Abadin H, Fay M, Yu D, Tencza B, Ingerman L, et al. Toxicological Profile for Chromium. Atlanta, GA: Agency for Toxic Substances and Disease Registry, US; 2012.
This work is licensed under a Creative Commons Attribution 4.0 International License.